Back
iShares 20+ Year Treasury Bond ETF Vs. Kymera Therapeutics Industry Stock Comparison
Sell
40
TLT
iShares 20+ Year Treasury Bond ETF
Last Price:
$86.50
Seasonality Move:
1.52%
Buy
77
KYMR
Kymera Therapeutics
Last Price:
$45.92
Seasonality Move:
30.84%
Sell
40
iShares 20+ Year Treasury Bond ETF (TLT)
is a Sell
Is iShares 20+ Year Treasury Bond ETF a Buy, Sell or Hold?
-
The current iShares 20+ Year Treasury Bond ETF [TLT] share price is $86.49. The Score for TLT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
TLT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
-
The current Kymera Therapeutics [KYMR] share price is $45.87. The Score for KYMR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TLT Stock Price Chart
What is iShares 20+ Year Treasury Bond ETF's stock price today?
-
The iShares 20+ Year Treasury Bond ETF share price today is $86.49The current trend is relatively stagnant and TLT is experiencing slight buying pressure.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $45.87The current trend is moderately bullish and KYMR is experiencing slight buying pressure.
TLT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 51.38 | Buy |
Chaikin Money Flow: | 7429116 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.04 - 86.54) | Buy |
Bollinger Bands (100): | (86.19 - 90.41) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.05 | Buy |
Relative Strength Index (14 RSI): | 67.57 | Buy |
Chaikin Money Flow: | 251231 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.82 - 47.48) | Buy |
Bollinger Bands (100): | (27.31 - 40.79) | Buy |
TLT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.33 | Buy |
20-day SMA: | 85.85 | Buy |
50-day SMA: | 86.69 | Sell |
200-day SMA: | 90.58 | Sell |
8-day EMA: | 86.29 | Buy |
20-day EMA: | 86.17 | Buy |
50-day EMA: | 86.84 | Sell |
200-day EMA: | 89.63 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 47.09 | Sell |
20-day SMA: | 41.33 | Buy |
50-day SMA: | 34.42 | Buy |
200-day SMA: | 39.62 | Buy |
8-day EMA: | 46.1 | Sell |
20-day EMA: | 42.54 | Buy |
50-day EMA: | 37.49 | Buy |
200-day EMA: | 36.91 | Buy |
iShares 20+ Year Treasury Bond ETF Earnings Growth & TLT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.76 per share, and a decrease next year of $0.40 per share.
iShares 20+ Year Treasury Bond ETF Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |